AstroMelanin is a biotechnology product based on the production of a substance from Antarctic microorganisms.Studies of the substance have been performed by the largest scientists in the field of oncology in Russia, USA, South Korea and Japan. Inventions have been confirmed by patents and awarded with prizes at the International Salons of Inventions Concourlepin, Paris and "Eureka", Brussels (gold medal)

“AstroMelanin” received approving reviews and support from the heads of three oncological centers in Russia, who assessed it as a promising drug that reflected the latest methods in the treatment of tumor diseases.

The work was performed by a team of famous Russian scientists oncologists under the leadership of the Director of the Russian Oncological Center named after N.N.Blokhin RAMS Academician N.N.Trapeznikov and Director of the Research Institute of Experimental Diagnostics and Therapy of Tumors of the Blokhin Russian Cancer Research Center of the Russian Academy of Medical Sciences, Doctor of Medical Sciences, Professor, Academician of the RMTA A.Y.Baryshnikov.

Research conducted by a world-known Doctor, D. Van Hoff, Head of the Institute for Drug Development and Cancer Therapy in San-Antonio, Texas, USA, has shown that when exposed for six days, COMPLETELY inhibits the growth of human breast cancer cells

According to Dr. of Pharmacology, Professor of Medicine Robert A. Newman (Anderson Cancer Center, Houston, TX, USA), “The melanin-containing biopolymer “AstroMelanin” has a clear cytotoxic activity against cancer cells and appears to be interesting and promising.

Producing strains, AstroMelanin and methods of application are protected by patents of the Russian Federation, their authors / inventors S.P. Lyakh, M.L. Boulgak, A.G. Isaev and are medalists of international salons of inventions in Brussels “Eureka 98,99, 2001”, in Paris “Jumping Lepin 99, 2000”, in Moscow “Archimedes” - 99,2000, 2001, in Geneva-2002, etc.